The Home of the Life Sciences Industry
Explore Latest News
- Genentech Flu Drug Scores Another Late-Stage Win
- HotSpot Therapeutics Emerges From Stealth Mode With $45 Million to Aim at New Biological Targets
- Could Amgen Eye Alexion as a M&A Target to Offset Neulasta Decline?
- China’s Ascentage Pharma Snags $150 Million to Support Pipeline Development
- New Study Says DNA Damage From CRISPR-Cas9 Gene-Editing Has Been Underestimated